OverviewChartNewsTraderScreen

Soc. Generale Knock-Out Novo-Nord.../  DE000SY0E367  /

EUWAX
2024-06-13  9:18:07 AM Chg.-0.06 Bid10:00:40 PM Ask10:00:40 PM Underlying Strike price Expiration date Option type
2.44EUR -2.40% -
Bid Size: -		 -
Ask Size: -		 - 1,168.6257 DKK 2078-12-31 Put
GlobeNewswire 3:10 PM Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Chil...
GlobeNewswire 12:00 PM Biosplice Announces Collaboration with Novo Nordisk in Diabetes
GlobeNewswire 06-11 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
GlobeNewswire 06-10 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire 06-10 Veru to Present at the American Diabetes Association's 84th Scientific Sessions
GlobeNewswire 06-03 Aeterna Zentaris and Ceapro Complete Merger Transaction
GlobeNewswire 06-03 Aeterna Zentaris and Ceapro Complete Merger Transaction
GlobeNewswire 05-31 Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia...
GlobeNewswire 05-30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 05-22 Veru to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 05-15 Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Cl...
GlobeNewswire 05-15 Aeterna Zentaris Reports First Quarter 2024 Financial Results
GlobeNewswire 05-14 Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Sci...
GlobeNewswire 05-09 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 05-07 Vect-Horus to Take Part in a Roundtable Discussion at Viva Technology Conference
TeleTrader 04-25 Europe opens mostly down after corporate earnings
GlobeNewswire 04-22 Vect-Horus Publication in Pharmaceutics Outlines How Vectors Can Improve Delivery of Therapeutics to...
GlobeNewswire 04-22 SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into cli...
GlobeNewswire 04-22 SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into cli...
GlobeNewswire 04-11 Robbins LLP is Investigating the Acquisition of Catalent, Inc. (CTLT) by Novo Holdings
GlobeNewswire 04-02 Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT Peptide Targeting C...
GlobeNewswire 04-02 Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
GlobeNewswire 03-28 Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategi...
GlobeNewswire 03-27 Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completio...
GlobeNewswire 03-25 Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the ...